MANIPAL HEALTH ENTERPRI L (MANIPALHOS) Share Price Falls 2.16% Today

MANIPAL HEALTH ENTERPRI L Share Price fell to Rs 714 on 07 September 2026, down 2.16% from the previous close of Rs 729.75, taking the company’s market capitalisation to Rs 95,989.65 crore. The stock remained within an intraday range of Rs 711.05 to Rs 727.7, making it a notable move in a large-cap Healthcare counter.

The supplied data confirms the decline but does not identify a company-specific trigger. What is visible from the session numbers is that the stock opened at Rs 726.75, stayed below the previous close through the day, and recorded turnover of Rs 3.56 crore. That means the current update is best read as a market data snapshot rather than an explanation of causation.

Why is it being watched? Beyond the day’s move, the company carries a P/E ratio of 107.57 and a P/B ratio of 5.26, while ROE stands at 12.95% and ROCE at 13.93%. Those figures place the stock in an interesting position: it is a very large company within Hospital & Healthcare Services, but its valuation is still richer than many benchmark comparisons. That combination often keeps investor attention elevated during a down day.

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 714
Previous Close	Rs 729.75
Today's Move	-Rs 15.75 (-2.16%)
Open	Rs 726.75
High	Rs 727.7
Low	Rs 711.05
Turnover	Rs 3.56 crore
Market Capitalisation	Rs 95,989.65 crore
Market Cap Category	Large Cap

MANIPAL HEALTH ENTERPRI L Share Price Today reflects a session that stayed weak throughout. From an open of Rs 726.75, the stock slipped to a low of Rs 711.05 and was trading at Rs 714 at the time of the update. The day’s high was Rs 727.7, still below the previous close of Rs 729.75, so the stock never crossed back into positive territory during the observed session.

In absolute terms, the move was a decline of Rs 15.75, equal to 2.16%. For a large-cap stock, that is enough to bring added focus from traders and longer-term investors alike, especially when the price is sitting close to the day’s lower end. Turnover of Rs 3.56 crore indicates active value traded, even though the dataset does not provide a directional interpretation beyond that.

From a pure tape-reading perspective, the main takeaway is simple: the stock showed sustained intraday weakness rather than an early drop followed by a meaningful recovery. The next question is whether that price action sits against an expensive, average or relatively moderate fundamental profile.

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 95,989.65 crore
P/E Ratio	107.57x
P/B Ratio	5.26x
ROE	12.95%
ROCE	13.93%
EPS	Rs 6.78
Book Value Per Share	Rs 138.69
Dividend Yield	0%

MANIPAL HEALTH ENTERPRI L Share Price is attached to a business valued at Rs 95,989.65 crore, firmly placing it in the large-cap bracket. Yet the more striking part of the fundamental profile is valuation. A P/E ratio of 107.57 means the stock trades at more than 107 times earnings, while the P/B ratio of 5.26 shows the market values it at over five times book value.

Profitability, however, is less extreme than the valuation headline. ROE stands at 12.95% and ROCE at 13.93%, suggesting moderate return ratios rather than sector-leading ones. EPS is Rs 6.78 and book value per share is Rs 138.69, offering reference points for earnings and accounting net worth. Dividend yield is 0, so the available dataset does not suggest an income-driven investment case.

That balance matters. A company can trade at high multiples when the market places a premium on scale, position or expectations, but today’s figures alone only show that valuation is rich while profitability is closer to the middle of the industry range. To understand that better, it helps to compare the stock with the broader Healthcare benchmark and with listed peers.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Hospital & Healthcare Services
Benchmark Scope	same industry
Company P/E Ratio	107.57x
Benchmark Median P/E	46.45x
Benchmark Average P/E	101.64x
Benchmark P/E Range	7.87x to 1,488.32x
Company P/B Ratio	5.26x
Benchmark Median P/B	3.35x
Benchmark Average P/B	4.2x
Company ROE	12.95%
Benchmark Median ROE	12.77%
Benchmark Average ROE	13.51%
Company ROCE	13.93%
Benchmark Median ROCE	15.34%
Benchmark Average ROCE	3.27%
Company Market Capitalisation	Rs 95,989.65 crore
Benchmark Median Market Cap	Rs 519.09 crore
Benchmark Average Market Cap	Rs 11,295.38 crore

The benchmark covers 66 companies in the same Hospital & Healthcare Services industry. Against that set, the company’s P/E of 107.57 is far above the median of 46.45 and modestly above the average of 101.64. The full range, from 7.87 to 1,488.32, is very wide, so the stock is expensive relative to the centre of the pack without being near the most stretched point in the industry.

P/B shows a similar pattern. The company stands at 5.26 versus an industry median of 3.35 and average of 4.2. ROE of 12.95% is slightly above the median of 12.77% but below the average of 13.51. ROCE of 13.93% is below the median of 15.34% but above the reported average of 3.27. Market capitalisation, meanwhile, is far above both the median of Rs 519.09 crore and the average of Rs 11,295.38 crore, highlighting how large this company is within its industry group.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Apollo Hospitals Enterprise	APOLLOHOSP	1,24,661.3	59.66	12.87	23.54	21.73
Max Healthcare Institute	MAXHEALTH	95,871.06	65.8	8.77	14.53	14.97
Fortis Healthcare	FORTIS	68,701.19	65.56	6.76	11.32	14.07
Aster DM Healthcare	ASTERDM	68,496.02	214.94	13.79	9.32	11.46
Global Health	MEDANTA	39,493.23	71.01	9.61	15.12	19.38

MANIPAL HEALTH ENTERPRI L Share Price also draws attention because the company’s valuation does not sit cheaply beside its closest peers. Its market cap of Rs 95,989.65 crore is almost the same as Max Healthcare Institute at Rs 95,871.06 crore, below Apollo Hospitals Enterprise at Rs 1,24,661.3 crore, and well above Global Health at Rs 39,493.23 crore.

On P/E, the company trades at 107.57, above Apollo at 59.66, Max at 65.8, Fortis at 65.56 and Global Health at 71.01, while remaining below Aster DM Healthcare at 214.94. On P/B, however, 5.26 is lower than Apollo’s 12.87, Max’s 8.77, Fortis’ 6.76, Aster’s 13.79 and Global Health’s 9.61. Profitability is mixed: ROE of 12.95% is above Fortis and Aster but below Apollo, Max and Global Health, while ROCE of 13.93% is close to Fortis, above Aster and below Apollo, Max and Global Health. In short, valuation looks full on earnings, but the returns profile does not clearly dominate the peer group.

Why Investors Are Watching MANIPAL HEALTH ENTERPRI L

• The stock fell 2.16% today to Rs 714 from the previous close of Rs 729.75.
• It is a large-cap Healthcare company with market capitalisation of Rs 95,989.65 crore.
• The P/E ratio of 107.57 is above the same-industry median of 46.45 and average of 101.64.
• ROE is 12.95% and ROCE is 13.93%, indicating moderate profitability.
• Peer comparison shows a richer P/E than Apollo, Max, Fortis and Global Health.

About MANIPAL HEALTH ENTERPRI L

The company is part of the Healthcare sector and operates in the Hospital & Healthcare Services industry. The supplied peer universe includes major listed names such as Apollo Hospitals Enterprise, Max Healthcare Institute, Fortis Healthcare, Aster DM Healthcare and Global Health, which helps place its scale and valuation in context.

Track MANIPAL HEALTH ENTERPRI L Share Price on Univest

UseMANIPAL HEALTH ENTERPRI L (MANIPALHOS) live share-price page,Univest top decliners screener,Univest market blogsto review live stock data, top decliners and related market analysis.

Frequently Asked Questions

Why is the stock falling today?

Ans. The stock fell 2.16% to Rs 714 from the previous close of Rs 729.75. The supplied data confirms the decline and intraday weakness, but it does not identify a company-specific catalyst.

What is the current price today?

Ans. The current price is Rs 714 at the time of the update. The stock opened at Rs 726.75, touched a high of Rs 727.7 and a low of Rs 711.05.

What is the market cap?

Ans. Market capitalisation stands at Rs 95,989.65 crore, placing the company in the Large Cap category. The company operates in the Healthcare sector. Its P/E ratio is 107.57x. ROE is 12.95% and ROCE is 13.93%.

What does the P/B ratio show?

Ans. The P/B ratio is 5.26, higher than the industry median of 3.35 and average of 4.2. The company trades at a P/E ratio of 107.57x. The relevant peer median P/E is 46.45x.

How does it compare with Apollo and Max Healthcare?

Ans. Its market cap is close to Max Healthcare but below Apollo Hospitals. Its P/E of 107.57 is above both Apollo’s 59.66 and Max’s 65.8. Comparable listed companies include Apollo Hospitals Enterprise, Max Healthcare Institute, Fortis Healthcare.